Background {#Sec1}
==========

Diabetes mellitus is one of the most prevalent diseases worldwide, imposing a relevant epidemiological and clinical burden, both in terms of deaths and morbidities. The prevalence of diabetes is increasing both in developed and developing countries, and has doubled over the past three decades, with almost 80% of diabetic patients living in less developed countries \[[@CR1], [@CR2]\]. Population aging, lifestyle changes, lack of mobility, and many other factors characterizing modern life have contributed to such an increase \[[@CR3]\]. In 2014, the prevalence of diabetes in people aged greater than 18 years in the world was about 8.5%. It is anticipated that diabetes will be the seventh cause of death by 2030, and, despite all efforts to control the disease, it still remains one of the major public health challenges \[[@CR4]\]. The number of people with diabetes is expected to rise up to about 592 million by 2035 \[[@CR5]\]. The prevalence of diabetes in the Middle East and North Africa is about 10.9%. In these areas, about 35 million people are affected by diabetes, with Iran having the highest prevalence (9.94%) among the countries of the Middle East \[[@CR6]\].

Such concerns necessitate adequate health policies in order to control and prevent diabetes \[[@CR7]\]. This disorder represents a chronic disease associated with micro- and macro-vascular complications, which dramatically impact on general health status \[[@CR8]\]. Studies have shown that such complications can affect physical, mental and social life of people, modifying and interfering with their usual every day functioning \[[@CR9]\]. Hence, treatments of diabetes are usually evaluated based on their effect on health status \[[@CR10]\], which, as a key factor in effectiveness studies, refers, indeed, to the mental, physical and social status of the patient \[[@CR11]\]. Considering the general health status among diabetic patients can provide care givers with a better understanding of patients' conditions, indicating which health provisions are necessary for a proper management of the disease \[[@CR12]\].

To assess general health status among diabetes patients, a variety of questionnaires have been developed that can measure different dimensions of the patients' life. The Short-Form 36 (SF-36) questionnaire is one of the most commonly used instruments \[[@CR13]\]. It includes 36 questions distributed across eight domains (namely, vitality, physical function, body pain, health perception, physical role, emotional role, social role and mental health) \[[@CR14], [@CR15]\].

Various studies have been conducted to assess Iranian diabetic population's quality of life. Such information can be helpful for measuring the severity of complications and designing and implementing appropriate healthcare policies. In 2013, a review study was conducted in Iran on health status in diabetic patients. In this study, the assessment of health status of diabetics was based on all questionnaires used in Iran. Authors suggested that a meta-analysis study could better provide information about health status in diabetic patients \[[@CR16]\]. Therefore, the aim of this study was to estimate general health status among Iranian diabetic patients through a systematic review and meta-analysis of studies utilizing a specific instrument, namely the SF-36 questionnaire.

Methods {#Sec2}
=======

Literature search {#Sec3}
-----------------

The current study has been performed according to the "The Meta-analysis of Observational Studies in Epidemiology" (MOOSE) guidelines \[[@CR17]\]. (Additional file [1](#MOESM1){ref-type="media"}).

Two authors independently searched different scholarly electronic databases: namely, EMBASE, PubMed, ISI/Web of Sciences (WOS), MEDLINE via Ovid, PsycoINFO, as well as Iranian databases (MagIran, Iranmedex, and SID). These databases were systematically searched from January 2000 to December 2017 using the following search strategies: ("general health status") AND ("Short form 36" OR "SF-36" OR "SF-36 health survey questionnaire" OR "Short form-36 health survey questionnaire") AND ("Diabetes" OR "Diabetic") AND "Iran". Studies were searched both in English and Persian (no language filter applied). Reference lists of each included study were also scanned and hand-searched for possible related studies.

### Inclusion/ criteria {#Sec4}

Studies with the following criteria were included if: i) utilizing the SF-36 questionnaire for investigating general health status among Iranian populations, ii) reporting an average score for the eight domains of the questionnaire, iii) reporting both Physical Component Summary (PCS) and Mental Components Summary (MCS) indicators, and iv) reporting means with standard errors (SE) or standard deviations (SD). Both cross-sectional or case-control studies were considered.

### Exclusion criteria {#Sec5}

Studies were excluded if: i) designed as reviews, letters to the editor, editorials, expert opinions, commentaries, clinical trials, case-reports, case-series, or ii) not reporting quantitative details of the SF-36 questionnaire.

### Quality assessment {#Sec6}

The methodological quality of the studies was evaluated using the "A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions" (ACROBAT-NRSI) \[[@CR18]\].

### Data extraction {#Sec7}

Two authors (MB and NLB) extracted the data from the studies, and if there was a controversy between them, another author (AA) resolved the issue. The name of first authors of the studies, the year of publication, the place where the studies were conducted, the number of participants, the duration of diabetes, the design, and the mean scores of SF-36 domains were extracted.

### Statistical analysis {#Sec8}

The pooled value of the mean of overall scores, as well the scores of the eight domains of the questionnaire and the PCS and MCS scores were calculated as the mean and SE. Random-effect model was used and the means were reported with their 95% confidence interval (CI). To evaluate the heterogeneity among studies, I^2^ test was used \[[@CR19]\]. For evaluating the potential sources of heterogeneity, subgroup analyses based on the study design, sample size and type of diabetes (type 1 and type 2 diabetes) were conducted. Sensitivity analysis was performed to ensure that the results were stable. This analysis was also performed based on the year of publication. Egger's regression test was used to assess the publication bias \[[@CR20]\].

Finally, case-control studies were pooled together, computing the standardized mean difference (SMD).

Figures with a *p*-value \< 0.05 were considered statistically significant. All data were analyzed using Stata 12.0 software (Stata Corp LP, College Station, TX).

Results {#Sec9}
=======

After the initial electronic database search, 378 studies were found. Eighty-three duplicate studies were deleted. The titles of the retrieved studies were reviewed and 258 studies were excluded due to lack of relevance to the topic. Then, the title and abstract of 37 remaining studies were reviewed by two authors independently and 21 studies were excluded with reason. Finally, the full texts of the remaining 16 studies were examined and, based on the inclusion/exclusion criteria, 14 studies were retained in the final analysis \[[@CR21]--[@CR34]\]. Figure [1](#Fig1){ref-type="fig"} summarizes the stages of the retrieval and selection of the studies.Fig. 1Flowchart of the study retrieval and selection

The included studies were conducted between 2011 and 2017. The total number of participants in the studies was 4492, ranging from 60 to 1847 people. The study designs varied across studies and were cross-sectional for 10 studies and case-control for 4 studies). Table [1](#Tab1){ref-type="table"} shows the main characteristics of the studies retained in the present systematic review and meta-analysis.Table 1The main characteristics of the included studies about general health status in Iranian patients with diabetesFirst authorYear of publicationMean score of general health statusSample sizeFemaleMaleAge (Mean ± SD)Type of diabetesDesign of studyDuration of diabetes (Year ± SD)Married (%)Setting (City)Setting (Province)Borzou201155.5316511154NAType 2Cross- SectionalNANAHamedanHamedanKhaledi201145.2319816632NAType 2Cross- Sectional1--580.8SannadajKurdistanSaadatjoo201228.52100544642.82 ± 16.57Type 2Case-ControlNA82BirjandSouth KhorasanTimareh201252.9735020414652.91 ± 11.7Both typeCross- SectionalNA86.9KermanshahKermanshahSadabadi201344.7260NANANAType 2Case-ControlNANATabrizEast AzerbaijanDarvishpoor Kakhki201346.21317952NAType 2Case-ControlNA80.2TehranTehranHadi201354.113002227850.98Both typeCross- SectionalNA84ShirazFarsDarvishpoor Kakhki201352.11140NANA47.3 ± 12.7Both typeCross- Sectional8.83 ± 6.10NATehranTehranMohammadshahi201551.81110515953.4 ± 8.12Type 2Cross- SectionalNANAAhvazKhuzestanKashfi201561.33124893559.65 ± 12.3Type 2Case-Control7.68 ± 6.9383.9LarestanFarsBorhaninejad201646.48120695171.32 ± 5.13Type 2Cross- SectionalNA73.4KermanKermanHajian-Tailaki201656.2774737237568 ± 7.6 in male and 67.7 ± 7.9 in femaleType 2Cross- SectionalNANABabolMazandaranMazloomy Mahmood Abad201759.27100594151.92 ± 11.53Type 2Cross- SectionalNA94SirjanKermanGholami201751.111847128955859.65 ± 12.3Type 2Cross- SectionalNA19.9NishaburRazavi Khorasan

The quality assessment of the risk of bias of the included studies is shown in Table [2](#Tab2){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}.Table 2Risk of Bias Assessment of included studies based on the ACROBAT-NRSI instrumentStudyDomains of biasBias due to confoundingBias in selection of participantsBias in measurement of interventionsBias due to departures from intended interventionsBias due to missing dataBias in measurement of outcomesBias in selection of reported resultsBorzouModerate riskLow riskLow riskLow riskLow riskLow riskLow riskKhalediLow riskLow riskLow riskModerate riskLow riskLow riskModerate riskSaadatjooSerious riskLow riskSerious riskModerate riskSerious riskModerate riskSerious riskTimarehSerious riskModerate riskLow riskModerate riskModerate riskLow riskModerate riskSadabadiModerate riskLow riskModerate riskSerious riskModerate riskModerate riskLow riskDarvishpoor KakhkiSerious riskLow riskLow riskModerate riskLow riskModerate riskLow riskHadiLow riskLow riskModerate riskLow riskLow riskLow riskLow riskDarvishpoor KakhkiModerate riskLow riskLow riskLow riskLow riskModerate riskLow riskMohammadshahiLow riskModerate riskLow riskLow riskLow riskModerate riskLow riskKashfiLow riskLow riskLow riskLow riskLow riskLow riskModerate riskBorhaninejadModerate riskLow riskModerate riskModerate riskLow riskLow riskLow riskHajian-TailakiLow riskLow riskLow riskModerate riskModerate riskLow riskLow riskMazloomy Mahmood AbadLow riskModerate riskLow riskLow riskLow riskLow riskLow riskGholamiModerate riskLow riskLow riskModerate riskLow riskLow riskLow riskFig. 2The result of quality assessment of risk of bias of included studies

The mean general health status using SF-36 based on the random-effect model in diabetic patients of Iran was 51.9 (95% CI: 48.64 to 53.54). The lowest health status was observed in the study of Saadatjoo with a score of 28.52 and the highest in Kashifi's study, with a value of 61.33. Figure [3](#Fig3){ref-type="fig"} shows the overall general health status among the included studies.Fig. 3The Mean health status in Iranian diabetic patients (2011--2017), based on the random-effects model

Using the Egger's test, no publication bias could be detected (*p* = 0.859, see Fig. [4](#Fig4){ref-type="fig"}).Fig. 4Probability of publication bias in the included studies

To investigate the possible sources of heterogeneity between studies, subgroup analysis was conducted based on study design, sample size and study quality. Table [3](#Tab3){ref-type="table"} shows the results of subgroup analysis.Table 3The results of subgroup analysisVariablesNumber of studiesNumber of participantsMean score of general health status (95% CI)I^2^*P*-valueDesign of studies Cross-sectional10407752.32 (50.02--54.62)86.8%0.001 Case-control441546.47 (38.87--54.08)93.3%0.001Sample size ≤120661449.58 (43.11--56.05)92%0.001 \> 1208387851.60 (48.95--54.24)90.7%0.001Type of diabetes Type 211370250.46 (47.43--53.49)92.46%0.001 Both type (type 1 and 2)379053.22 (51.37--55.07)0%0.001

For further evaluation of sources of heterogeneity, the results of meta-regression were analyzed based on the year of publication and the sample size of studies, as presented in Table [4](#Tab4){ref-type="table"}. The results showed that the quality of life of diabetic patients has increased on a yearly basis and has decreased based on the sample size. However, none of the results were statistically significant.Table 4The results of meta-regressionVariablesCoefficientS.E.t*P*-valueLower 95%Upper 95%Year1.361.071.270.22−0.993.73Sample size−0.000.00−0.220.82−0.010.00

The results based on the eight domains of the SF-36 questionnaire are presented in Table [5](#Tab5){ref-type="table"}. The mean scores of PCS and MCS are shown in Figs. [5](#Fig5){ref-type="fig"} and [6](#Fig6){ref-type="fig"}**.** The mean of PCS was 52.92 \[95% CI: 49.46--56.38\], while the mean of MCS was 51.02 \[95% CI: 46.87--55.16\].Table 5The health status based on the 8 domains of the SF-36 questionnaireVariablesMean (95% CI)Heterogeneity*P*-value of publication biasI^2^*P*-valuePhysical function61.62 (55.70--67.53)98.6%0.0010.78Role physical49.96 (44.50--55.41)95.6%0.0010.83Body pain52.26 (48.47--56.04)95.8%0.0010.57General health47.34 (44.15--50.53)96.5%0.0010.01Vitality46.99 (43.28--50.69)97.4%0.0010.64Social function57.86 (46.87--68.85)99.7%0.0010.15Role emotional50.38 (45.29--55.47)97.4%0.0010.28Mental health47.79 (40.06--55.52)99.6%0.0010.32Fig. 5The Physical component summaries (PCS)Fig. 6The mental component summaries (MCS)

Finally, case-control studies were pooled together (Fig. [7](#Fig7){ref-type="fig"}). The general health status of diabetic patients compared to healthy controls was lower with a SMD of − 0.84 \[95% CI: -1.83 to 0.51\] and compared to the group of patients with tuberculosis with a SMD of 0.44 \[95% CI: 0.21- 0.67\].Fig. 7The results of pooling together case-control studies

Discussion {#Sec10}
==========

In the 14 studies included in this systematic review and meta-analysis, numerous complications and co-morbidities were reported in people with diabetes. Health policy- and decision-makers should pay attention to the implications of the reduced general health status in diabetic patients in Iran. Various studies have, indeed, shown that health status is an independent prognostic predictor of survival and hospitalization rate in patients with peripheral arterial and renal patients, and of mortality in patients with coronary heart disease \[[@CR35]--[@CR38]\].

General health status is decreased in diabetic patients \[[@CR39]\], when compared to the health status of general population, which, in a recent study, reported an average score of 67.69 ± 14.78 \[[@CR40]\]. Healthcare providers should be aware of the patients' perspective and their perceived health. Preventing further diabetes complications and providing better conditions for patients' lives is fundamental. Physical and mental interventions can improve the health status of diabetic patients and avoid, or at least delay, further deterioration \[[@CR41]\].

Our findings showed that the dimensions of physical and social function had the highest score whereas the lowest score was related to vitality and general health. The results of our study are consistent with the study done in Brazil \[[@CR42]\], whereas other studies reported higher values \[[@CR43]--[@CR45]\]. The level of access to health services, the economic and social conditions of people, the physical and mental conditions of individuals can, at least partially, explain these differences \[[@CR46], [@CR47]\]. Some studies point to the existence of health inequalities in that people with a higher socioeconomic status have more incentive and energy to change their livelihood and are more involved in their own health care processes \[[@CR48]\]. An important cross-sectional survey of 13 national samples from Asia, Australia, Europe and North America of 5104 patients with diabetes from the multinational study of Diabetes Attitudes, Wishes and Needs (DAWN) has shown that the reported levels of well-being, self-management, and diabetes control correlate with country, respondent demographic and disease characteristics, as well as with healthcare features \[[@CR49]\]. These findings have been replicated by a follow-up study \[[@CR50]\].

The findings of the present study indicate that diabetes dramatically affects vitality and general health domains; hence these areas should be given more attention when treating diabetic patients. In our study, MCS was less than PCS, which was consistent with the results of the Al-Shehri study \[[@CR51]\]. Various studies have been conducted to show that mental disorders such as depression in patients with diabetes can be remarkably observed. In a review, results showed that depression in diabetic patients had a negative effect on the treatment process and increased complications of the disease \[[@CR52]\].

It seems that the chronic and severe nature of diabetes mellitus in the long run leads to a decrease in the general health status \[[@CR53]\]. It should be noted that the core of the concept of reported/perceived health status is a feeling/perception of one's own health and, in fact, other aspects of the health status form a sense of health that is low in patients with diabetes. Affecting the emotional aspects impacts on energy and vitality of patients with diabetes. Other studies have also shown a decrease in vitality, with an increase of fatigue, depression, anxiety and stress problems, among patients with diabetes. Therefore, diabetes has a long-term negative effect on the health of patients. The decrease in the health status in patients with diabetes has also been replicated in other studies \[[@CR54]\].

These observations can be confirmed if we compare health status of Iranian subjects with diabetes with the health status of people with chronic-degenerative disorders, such as rheumatoid arthritis with an average score of 52.47 \[[@CR55]\], or cardiovascular disorders with a mean of 53.19 \[[@CR56]\], among others. Similarly, low scores have been found for asthma \[[@CR57]\] or chronic kidney disease \[[@CR58]\]. Scores even lower (40.43 ± 12.7) were reported for individuals with drug addiction \[[@CR59]\].

In meta-analysis studies, taking into account potential sources of heterogeneity is crucial \[[@CR60]\]. To investigate this aspect, we performed subgroup-analysis based on each SF-36 scale domain. The results of meta-regression were also studied for further evaluation of heterogeneity sources, which showed an increased average health status of diabetic patients based on the year of publication, even though not statistically significant. In recent years the status of services provided to diabetics is on the rise, but it seems that many of the services provided to them are not of sufficient standards, and the quality of care for these patients should be monitored more closely by healthcare providers in Iran.

However, this study has some limitations that should be properly mentioned. First, the primary studies missed to give some complementary information about patients, such as sex, other illnesses/co-morbidities, education level and income. Second, a high level of heterogeneity was observed, which can be attributed to methodological differences. Third, the health status in diabetic patients has not been studied in many Iranian provinces, which can challenge the generalizability of our estimation to all Iranian diabetic population.

Conclusion {#Sec11}
==========

The findings of this study showed that general health status in Iranian diabetic patients is low. Health policy- and decision-makers should work to improve the health status in these patients and take appropriate interventions. Therefore, it is recommended to look at important factors such as patients' attitudes in changing and improving their lifestyle. A combination of both clinical and non-clinical interventions should be targeted at increasing the standard of living of these patients.
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ACROBAT-NRSI

:   A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions

BP

:   Bodily pain

CI

:   Confidence intervals

ERF

:   Emotional role functioning

GHP

:   General health perceptions

MCS

:   Mental Component Summary

MeSH

:   Medical Subject Headings

MH

:   Mental health

PCS

:   Physical Component Summary

PF

:   Physical functioning

PRF

:   Physical role functioning

PROs

:   Patient-reported outcomes

SF-36

:   The Short-Form 36

SID

:   Scientific Information Database

SMD

:   Standardized Mean Difference

SRF

:   Social role functioning

VT

:   Vitality

WOS

:   Web of Science
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